476 related articles for article (PubMed ID: 17212694)
21. Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors.
Gobert A; Di Cara B; Cistarelli L; Millan MJ
J Pharmacol Exp Ther; 2003 Apr; 305(1):338-46. PubMed ID: 12649387
[TBL] [Abstract][Full Text] [Related]
22. Microdialysis measures of functional increases in ACh release in the hippocampus with and without inclusion of acetylcholinesterase inhibitors in the perfusate.
Chang Q; Savage LM; Gold PE
J Neurochem; 2006 May; 97(3):697-706. PubMed ID: 16579834
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit.
Gil-Bea FJ; García-Alloza M; Domínguez J; Marcos B; Ramírez MJ
Neurosci Lett; 2005 Feb; 375(1):37-41. PubMed ID: 15664119
[TBL] [Abstract][Full Text] [Related]
24. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
25. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase.
Xie W; Stribley JA; Chatonnet A; Wilder PJ; Rizzino A; McComb RD; Taylor P; Hinrichs SH; Lockridge O
J Pharmacol Exp Ther; 2000 Jun; 293(3):896-902. PubMed ID: 10869390
[TBL] [Abstract][Full Text] [Related]
26. Trafficking of the muscarinic m2 autoreceptor in cholinergic basalocortical neurons in vivo: differential regulation of plasma membrane receptor availability and intraneuronal localization in acetylcholinesterase-deficient and -inhibited mice.
Decossas M; Bloch B; Bernard V
J Comp Neurol; 2003 Jun; 462(3):302-14. PubMed ID: 12794734
[TBL] [Abstract][Full Text] [Related]
27. N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine.
Cerbai F; Giovannini MG; Melani C; Enz A; Pepeu G
Eur J Pharmacol; 2007 Oct; 572(2-3):142-50. PubMed ID: 17643410
[TBL] [Abstract][Full Text] [Related]
28. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat.
Milatovic D; Dettbarn WD
Toxicol Appl Pharmacol; 1996 Jan; 136(1):20-8. PubMed ID: 8560475
[TBL] [Abstract][Full Text] [Related]
29. MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.
García-Gómez BE; Fernández-Gómez FJ; Muñoz-Delgado E; Buée L; Blum D; Vidal CJ
J Mol Neurosci; 2016 Apr; 58(4):411-5. PubMed ID: 26697857
[TBL] [Abstract][Full Text] [Related]
30. Cholinesterases in development and disease.
Anglister L; Etlin A; Finkel E; Durrant AR; Lev-Tov A
Chem Biol Interact; 2008 Sep; 175(1-3):92-100. PubMed ID: 18571632
[TBL] [Abstract][Full Text] [Related]
31. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase.
Erb C; Troost J; Kopf S; Schmitt U; Löffelholz K; Soreq H; Klein J
J Neurochem; 2001 Apr; 77(2):638-46. PubMed ID: 11299326
[TBL] [Abstract][Full Text] [Related]
32. Rationale for diagnosing deficiency of ChEs and for applying exogenous HuChEs to the treatment of diseases.
Shen ZX
Med Hypotheses; 2008; 70(1):43-51. PubMed ID: 17587508
[TBL] [Abstract][Full Text] [Related]
33. Cholinergic activation of the murine trachealis muscle via non-vesicular acetylcholine release involving low-affinity choline transporters.
Nassenstein C; Wiegand S; Lips KS; Li G; Klein J; Kummer W
Int Immunopharmacol; 2015 Nov; 29(1):173-80. PubMed ID: 26278668
[TBL] [Abstract][Full Text] [Related]
34. Prolonged treatment with donepezil increases acetylcholinesterase expression in the central nervous system.
Zivin M; Pregelj P
Psychiatr Danub; 2008 Jun; 20(2):168-73. PubMed ID: 18587286
[TBL] [Abstract][Full Text] [Related]
35. Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
Liang YQ; Tang XC
Acta Pharmacol Sin; 2006 Sep; 27(9):1127-36. PubMed ID: 16923332
[TBL] [Abstract][Full Text] [Related]
36. Cholinesterases regulation in the absence of ColQ.
Sigoillot SM; Bourgeois F; Legay C
Chem Biol Interact; 2010 Sep; 187(1-3):84-9. PubMed ID: 20153305
[TBL] [Abstract][Full Text] [Related]
37. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Bosak A; Gazić I; Vinković V; Kovarik Z
Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
[TBL] [Abstract][Full Text] [Related]
38. Expression and possible functions of the cholinergic system in a murine embryonic stem cell line.
Paraoanu LE; Steinert G; Koehler A; Wessler I; Layer PG
Life Sci; 2007 May; 80(24-25):2375-9. PubMed ID: 17459421
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
40. Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation.
Darvesh S; Grantham DL; Hopkins DA
J Comp Neurol; 1998 Apr; 393(3):374-90. PubMed ID: 9548556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
